Global Fund secures deal to slash HIV treatment price; to benefit over 19 million Subject: Science Section: Health Introduction: The Global Fund, partners, and generic drug makers achieved a 25% cost reduction for first-line HIV treatment, now priced at under $45 per person annually. This has the potential to expand HIV services in […]